Nymox Pharmaceutical Net Profit Margin Growth & History (NYMXF)
Nymox Pharmaceutical's net profit margin was −234,760.00% for fiscal 2020.
View full Nymox Pharmaceutical company overviewNymox Pharmaceutical annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −234,760.00% | −223413.45 pp |
| 2019 | 2019-12-31 | −11,346.55% | −7803.41 pp |
| 2018 | 2018-12-31 | −3,543.14% | +2451.95 pp |
| 2017 | 2017-12-31 | −5,995.09% | −1378.89 pp |
| 2016 | 2016-12-31 | −4,616.20% | −3968.10 pp |
| 2015 | 2015-12-31 | −648.10% | — |
Nymox Pharmaceutical quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2020 | 2020-03-31 | −52,300.00% | −42733.33 pp |
| Q4 2019 | 2019-12-31 | −9,951.85% | +4363.94 pp |
| Q3 2019 | 2019-09-30 | −6,310.26% | +667.24 pp |
| Q2 2019 | 2019-06-30 | −25,720.00% | −22971.14 pp |
| Q1 2019 | 2019-03-31 | −9,566.67% | −7814.04 pp |
| Q4 2018 | 2018-12-31 | −14,315.79% | −11176.17 pp |
| Q3 2018 | 2018-09-30 | −6,977.50% | +7803.15 pp |
| Q2 2018 | 2018-06-30 | −2,748.86% | +27306.69 pp |
| Q1 2018 | 2018-03-31 | −1,752.63% | +1855.06 pp |
| Q4 2017 | 2017-12-31 | −3,139.62% | — |
| Q3 2017 | 2017-09-30 | −14,780.65% | — |
| Q2 2017 | 2017-06-30 | −30,055.56% | — |
| Q1 2017 | 2017-03-31 | −3,607.69% | — |
Nymox Pharmaceutical net profit margin trends
Over the last five fiscal years, Nymox Pharmaceutical's net profit margin decreased from −648.10% to −234,760.00%, a change of −234111.90 percentage points. The latest reported quarter, Q1 2020, shows −52,300.00%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nymox Pharmaceutical source filings ↗